In-vitro Toxicology Testing Market Analysis and Forecast to 2031: By Type (Absorption, Toxic Substance, Dose), Technology (Toxicogenomics, Cell Culture Technologies, Others), End-User (Cosmetics, Pharmaceuticals, Food, Others), and Region

In-vitro toxicology testing is a type of toxicology testing that is conducted using cells or other tissues that are cultured in a laboratory. This type of testing is used to assess the potential toxicity of a substance, and to determine how a substance may affect the function of cells or tissues. In-vitro toxicology testing is often used in the development of new drugs or chemicals, and in the assessment of environmental exposures.

Key Trends

One of the key trends in in-vitro toxicology testing is the use of new technologies to assess the toxicity of substances. In particular, there is a growing interest in the use of 3D cell culture systems for in-vitro toxicology testing.

Another key trend is the use of alternative methods to assess the toxicity of substances. In particular, there is a growing interest in the use of in-silico methods, which use computer models to predict the toxicity of substances.

Finally, there is a trend towards the use of more sophisticated methods to analyze the data from in-vitro toxicology tests. In particular, there is a growing interest in the use of machine learning techniques to analyze data from in-vitro toxicology tests.

Key Drivers

There are several key drivers of the in-vitro toxicology testing market.

Firstly, there is a growing awareness of the ethical concerns associated with animal testing, and an increasing number of consumers are demanding that companies switch to more humane testing methods.

Secondly, in-vitro testing is generally more accurate than animal testing, as it can more accurately replicate the human cellular environment.

Finally, in-vitro testing is often cheaper and faster than animal testing, which makes it increasingly attractive to companies.

Restraints & Challenges

In-vitro toxicology testing is a key tool for assessing the safety of chemicals and drugs. However, there are several key restraints and challenges associated with this type of testing.

First, in-vitro toxicology testing can be expensive and time-consuming.

Second, in-vitro toxicology testing may not always be able to identify all potential toxicity issues.

Finally, in-vitro toxicology testing may not be able to identify all potential side effects of a chemical or drug.

Market Segments

The in-vitro toxicology testing market is segmented by type, technology, end-user, and region. By type, the market is classified into absorption, toxic substance, and dose. On the basis of technology, it is bifurcated into toxicogenomics, cell culture technologies, and others. Based on end-user, it is divided into cosmetics, pharmaceuticals, food, and others. Region-wise, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

Key Players

The global in-vitro toxicology testing market includes players such as General Electric Company, Thermo Fisher Scientific In, Laboratory Corporation of America Holdings, Acacia Pharma Group Plc, Tesaro Inc, Helsinn Holding S.A., Heron Therapeutics Inc, AstraZeneca plc, Catalent Inc, Creative Biorray, and others.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. In-Vitro Toxicology Testing Market Outlook
3.1. In-Vitro Toxicology Testing Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Global In-Vitro Toxicology Testing Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Global In-Vitro Toxicology Testing Market
4.3. Economic Impact Analysis

Chapter 5. In-Vitro Toxicology Testing Market by Technology
5.1. Market Overview
5.2. Cell Culture Technologies
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Toxicogenomics
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. In-Vitro Toxicology Testing Market by End-Use
6.1. Market Overview
6.2. Cosmetics
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Pharmaceuticals
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Food
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.5. Others
6.5.1. Market Size and Forecast, 2021-2031 ($Million)
6.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. In-Vitro Toxicology Testing Market by Type
7.1. Market Overview
7.2. Absorption
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Toxic Substances
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Dose
7.4.1. Market Size and Forecast, 2021-2031 ($Million)
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. In-Vitro Toxicology Testing Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.3. North America In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.2.4. North America In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.2.5. North America In-Vitro Toxicology Testing Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.6.2. The U.S. In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.2.6.3. The U.S. In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.2.7. Canada
8.2.7.1. Canada In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.7.2. Canada In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.2.7.3. Canada In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.2.8. Mexico
8.2.8.1. Mexico In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.8.2. Mexico In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.2.8.3. Mexico In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.3. Europe In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.4. Europe In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.5. Europe In-Vitro Toxicology Testing Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.6.2. Germany In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.6.3. Germany In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.3.7. France
8.3.7.1. France In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.7.2. France In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.7.3. France In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.3.8. U.K.
8.3.8.1. U.K. In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.8.2. U.K. In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.8.3. U.K. In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.3.9. Spain
8.3.9.1. Spain In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.9.2. Spain In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.9.3. Spain In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.10.2. Italy In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.10.3. Italy In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.11.2. Rest of Europe In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.3.11.3. Rest of Europe In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific In-Vitro Toxicology Testing Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.4.4. Asia-Pacific In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.5. Asia-Pacific In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.6.2. China In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.4.6.3. China In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.4.7. India
8.4.7.1. India In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.7.2. India In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.4.7.3. India In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.4.8. Japan
8.4.8.1. Japan In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.8.2. Japan In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.4.8.3. Japan In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.9.2. South Korea In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.4.9.3. South Korea In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.4.10. Rest of APAC
8.4.10.1. Rest of APAC In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.10.2. Rest of APAC In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.4.10.3. Rest of APAC In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.3. Rest of the World In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.5.4. Rest of the World In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.5. Rest of the World In-Vitro Toxicology Testing Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.6.2. Latin America In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.5.6.3. Latin America In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.7.2. Middle East In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.5.7.3. Middle East In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

8.5.8. Africa
8.5.8.1. Africa In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.8.2. Africa In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.5.8.3. Africa In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.9. Rest of LAMEA
8.5.9.1. Rest of LAMEA In-Vitro Toxicology Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.9.2. Rest of LAMEA In-Vitro Toxicology Testing Market Size and Forecast by End-Use, 2021-2031, ($Million)
8.5.9.3. Rest of LAMEA In-Vitro Toxicology Testing Market Size and Forecast by Type, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. General Electric Company
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Thermo Fisher Scientific In.
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Laboratory Corporation of America Holdings
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Acacia Pharma Group Plc
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Tesaro Inc
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Helsinn Holding S.A.
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Heron Therapeutics Inc
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. AstraZeneca plc
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Catalent Inc
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Creative Biorray
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

Key Players
  • General Electric Company
  • Thermo Fisher Scientific In.
  • Laboratory Corporation of America Holdings
  • Acacia Pharma Group Plc
  • Tesaro Inc
  • Helsinn Holding S.A.
  • Heron Therapeutics Inc
  • AstraZeneca plc
  • Catalent Inc
  • Creative Biorray
Market Segmentation

By Type

  • Absorption
  • Toxic Substances
  • Dose

By Technology

  • Cell Culture Technologies
  • Toxicogenomics

By End-Use

  • Cosmetics
  • Pharmaceuticals
  • Food
  • Others

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

The global homecare oxygen concentrators market was valued…
A laparoscopic device is a small, handheld camera…
Intensive care unit (ICU) equipment is a type…
The global moisture analyzer market was valued at…
The global vitreoretinal surgery devices market was valued…
Magnetic resonance imaging (MRI) is a type of…
Joint pain injections are a type of treatment…
The global smart pills market was valued at…
The global sports medicine market was valued at…
Endoluminal suturing devices are devices that are used…